| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8K | -98.9% |
| R&D Expense | $4.7M | +24.0% |
| SG&A Expense | $6.3M | +39.5% |
| Operating Income | -$11.0M | -44.2% |
| Pre-tax Income | -$9.0M | +20.5% |
| Income Tax | $9K | -47.8% |
| Net Income | -$9.0M | +20.5% |
| EPS (Basic) | -$2.37 | -29.5% |
| EPS (Diluted) | -$2.37 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | +153.6% |
| Accounts Receivable | $175K | — |
| Current Assets | $5.2M | +106.2% |
| Total Assets | $7.4M | +43.9% |
| Current Liabilities | $1.4M | -14.2% |
| Total Liabilities | $1.7M | -24.6% |
| Stockholders' Equity | $5.7M | +95.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.2M | -38.3% |
| Capital Expenditures | $9K | -67.7% |
| Investing Cash Flow | -$379K | -19.2% |
| Financing Cash Flow | $13.3M | +122.6% |
| Free Cash Flow | -$10.2M | -37.9% |
| -29.5% |